⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockGermanyNasdaqGS

BNTX

BioNTech SE

Healthcare · Biotechnology

98.13USD

-0.5300 (-0.54%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(EUR)
1)

Issue Data

Last PxUSD / 98.13
P/E—
Dvd Ind Yld—
P/B1.39
P/S9.3
Curr EV/T12M EBITDA—
Mkt Cap (USD)24.7B
Curr EV (USD)—
2)

Per Share Data

EPS T12M-6.71
DPS1.91
Bk Val Per Sh82.20
Rev/Sh10.46
Cash/Sh53.60
Curr Shares Out251.2M
FCF/Sh1.76
3)

Cash Flow Analysis

P/CF36.3
Curr P/FCF55.4
CF/NI-0.4
Dvd P/O-28.7%
Cash Gen/Cash Reqd0.9
Csh Dvd Cov1.4
CFO/Sales25.6%
Eff Interest Rate5.1%
4)

Growth Potential

Dil EPS 1Y Gr-69.7%
Cap 1Y Gr-0.9%
BPS 1Y Gr-1.5%
R&D To Sales82.2%
Retention Rate128.7%
Rev 1Y Gr4.3%
FCF 1Y Gr-19.8%
Assets 1Y Gr-2.4%
5)

Profitability

EBITDA-0.6B
EBIT-1.2B
Operating Margin-46.7%
Pretax Margin-61.5%
Net Margin-63.6%
ROA-8.0%
ROE-9.3%
ROC—
Asset Turnover0.13
6)

Structure

Current Ratio7.85
Quick Ratio7.03
Debt/Assets1.6%
Debt/Com Eq1.8%
Net Debt/EBITDA16.83
Tot Debt/Capital1.7%
Gross Margin75.5%
EBIT/Int Exp-83.0

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years. This company reports in a different currency from the one its shares trade in, so any ratio dividing a market value by a statement figure crosses that boundary un-converted.